Biom’up announced Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director. Dr. Byloos’ international experience in the healthcare and medical equipment sectors, combined with his knowledge of the US market will contribute additional support to Biom’up’s management team as the commercial roll-out of its lead product, HEMOBLAST™ Bellows, hits North America. Currently CEO of Optegra Eye Health Care, he previously served as CEO and President of Handicare.